KR880001630A - 5-플루오로우라실 유도체 및 그의 용도 - Google Patents
5-플루오로우라실 유도체 및 그의 용도 Download PDFInfo
- Publication number
- KR880001630A KR880001630A KR1019870006895A KR870006895A KR880001630A KR 880001630 A KR880001630 A KR 880001630A KR 1019870006895 A KR1019870006895 A KR 1019870006895A KR 870006895 A KR870006895 A KR 870006895A KR 880001630 A KR880001630 A KR 880001630A
- Authority
- KR
- South Korea
- Prior art keywords
- fluorouracil
- fluorouracil derivative
- pyridyloxycarbonyl
- benzoyloxy
- ethoxymethyl
- Prior art date
Links
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical class FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 title claims 15
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical group O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 claims 8
- 206010028980 Neoplasm Diseases 0.000 claims 6
- 201000011510 cancer Diseases 0.000 claims 6
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims 5
- -1 6-benzoyloxy-3-cyano-2-pyridyloxycarbonyl Chemical group 0.000 claims 4
- 238000000034 method Methods 0.000 claims 4
- 229940035893 uracil Drugs 0.000 claims 4
- 230000001093 anti-cancer Effects 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 229910052698 phosphorus Inorganic materials 0.000 claims 1
- 239000011574 phosphorus Substances 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Description
Claims (10)
- 하기 일반식(I)로 표시되는 5-플루오로우라실 유도체.[상기 식중, Ra는 C1~C6알콕시메틸기이다].
- 제1항에 있어서, 5-플루오로우라실 유도체가 3-[3-(6-벤조일옥시-3-시아노-2-피리딜옥시카르보닐)벤조일]-1-에톡시메틸-5-플루오로우라실인 화합물.
- 하기 일반식(I)로 표시되는 5-플루오로우라실 유도체의 유효량 및 약학적으로 허용 가능한 담체로 구성되는 항암 조성물.[상기 식중, Ra는 C1~C6알콕시메틸기이다].
- 제3항에 있어서, 5-플루오로우라실 유도체가 3-[3-(6-벤조일옥시-3-시아노-2-피리딜옥시카르보닐) 벤조일]-1-에톡시메틸-5-플루오로우라실인 항암 조성물.
- 하기 일반식(1)로 표시되는 5-플루오로우라실 유도체의 유효량을 환자에게 투여함을 특징으로 하는 환자에 있어서 암의 치료방법.[상기 식중, Ra는 C1~C6알콕시메틸기이다].
- 제5항에 있어서, 5-플루오로우라실 유도체가 3-[3-6-벤조일옥시-3-시아노-2-피리딜옥시카르보닐)벤조일]-1-에톡시메틸-5-플루오로우라실인 암의 치료방법.
- 암 치료용 조성물을 제조하기 위한 하기 일반식(I)로 표시되는 5-플루오로우라실 유도체의 용도.[상기 식중, Ra는 C1~C6알콕시메틸기이다].
- 제7항에 있어서, 5-플루오로우라실 유도체가 3-[3-(6-벤조일옥시-3-시아노-2-피리딜옥시카르보닐)벤조일]-1-에톡시메틸-5-플루오로우라실인 암 치료용 조성물을 제조하기 위한 5-플루오로우라실 유도체의 용도.
- 암을 치료하기 위한 하기 일반식(1)로 표시되는 5-플루오로우라실 유도체의 용도.[상기 식중, Ra는 C1~C6알콕시메틸기이다].
- 제9항에 있어서, 5-플루오로우라실 유도체가 3-[3-(6-벤조일옥시-3-시아노-2-피리딜옥시카르보닐)벤조일]-1-에톡시메틸-5-플루오로우라실인 암을 치료하기 위한 5-플루오로우라실 유도체의 용도.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP176464/1986 | 1986-07-25 | ||
JP17646486 | 1986-07-25 | ||
JP86-176464 | 1986-07-25 | ||
JP86-181072 | 1986-07-30 | ||
JP181027/1986 | 1986-07-30 | ||
JP61181027A JPS63301880A (ja) | 1985-09-03 | 1986-07-30 | 5−フルオロウラシル誘導体 |
JP34161/1987 | 1987-02-17 | ||
JP87-34161 | 1987-02-17 | ||
JP62034161A JPS63201127A (ja) | 1987-02-17 | 1987-02-17 | 5−フルオロウラシル誘導体を含有する制癌剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR880001630A true KR880001630A (ko) | 1988-04-25 |
KR950011394B1 KR950011394B1 (ko) | 1995-10-02 |
Family
ID=27288338
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019870002961A KR950009857B1 (ko) | 1986-07-25 | 1987-03-30 | 5-플루오로우라실 유도체의 제조방법 |
KR1019870006895A KR950011394B1 (ko) | 1986-07-25 | 1987-07-01 | 5-플루오로우라실 유도체 및 그의 용도 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019870002961A KR950009857B1 (ko) | 1986-07-25 | 1987-03-30 | 5-플루오로우라실 유도체의 제조방법 |
Country Status (10)
Country | Link |
---|---|
KR (2) | KR950009857B1 (ko) |
CH (1) | CH671578A5 (ko) |
DE (1) | DE3709699C2 (ko) |
DK (1) | DK169520B1 (ko) |
ES (1) | ES2004904A6 (ko) |
FR (1) | FR2605006B1 (ko) |
GB (1) | GB2192880B (ko) |
IT (1) | IT1207785B (ko) |
NL (1) | NL194043C (ko) |
SE (1) | SE464303B (ko) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4864021A (en) * | 1984-10-30 | 1989-09-05 | Otsuka Pharmaceutical Co., Ltd. | 5-fluorouracil derivatives |
WO1990007334A1 (en) | 1989-01-05 | 1990-07-12 | Otsuka Pharmaceutical Co., Ltd. | Non-injection carcinostatic agent for suppressing occurrence of inflammation due to 5-fluorouracil and method for curing cancer |
EP0489181B1 (en) * | 1990-07-19 | 1996-10-02 | Otsuka Pharmaceutical Co., Ltd. | Solid preparation |
CN102574837B (zh) * | 2009-10-27 | 2013-11-27 | 德尔塔菲制药股份有限公司 | 新的5-氟尿嘧啶衍生物 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0323441B1 (en) * | 1984-10-30 | 1996-04-24 | Otsuka Pharmaceutical Co., Ltd. | 5-Fluorouracil derivatives |
JPS61114739A (ja) * | 1984-11-08 | 1986-06-02 | Mitsubishi Rayon Co Ltd | 不飽和カルボン酸製造用触媒の調製法 |
-
1987
- 1987-03-16 DK DK133387A patent/DK169520B1/da not_active IP Right Cessation
- 1987-03-18 SE SE8701118A patent/SE464303B/sv not_active IP Right Cessation
- 1987-03-18 ES ES8700756A patent/ES2004904A6/es not_active Expired
- 1987-03-23 CH CH1091/87A patent/CH671578A5/de not_active IP Right Cessation
- 1987-03-24 GB GB8706972A patent/GB2192880B/en not_active Expired - Fee Related
- 1987-03-25 DE DE3709699A patent/DE3709699C2/de not_active Expired - Fee Related
- 1987-03-30 IT IT8705150A patent/IT1207785B/it active
- 1987-03-30 NL NL8700742A patent/NL194043C/nl not_active IP Right Cessation
- 1987-03-30 KR KR1019870002961A patent/KR950009857B1/ko not_active IP Right Cessation
- 1987-03-31 FR FR878704500A patent/FR2605006B1/fr not_active Expired - Fee Related
- 1987-07-01 KR KR1019870006895A patent/KR950011394B1/ko not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
GB8706972D0 (en) | 1987-04-29 |
FR2605006B1 (fr) | 1990-01-12 |
FR2605006A1 (fr) | 1988-04-15 |
KR950009857B1 (ko) | 1995-08-29 |
DE3709699A1 (de) | 1988-02-04 |
ES2004904A6 (es) | 1989-02-16 |
SE8701118D0 (sv) | 1987-03-18 |
DK133387D0 (da) | 1987-03-16 |
GB2192880A (en) | 1988-01-27 |
NL8700742A (nl) | 1988-02-16 |
DK133387A (da) | 1988-01-26 |
IT1207785B (it) | 1989-06-01 |
KR950011394B1 (ko) | 1995-10-02 |
DK169520B1 (da) | 1994-11-21 |
NL194043B (nl) | 2001-01-02 |
KR880001635A (ko) | 1988-04-25 |
NL194043C (nl) | 2001-05-03 |
SE464303B (sv) | 1991-04-08 |
IT8705150A0 (it) | 1987-03-30 |
GB2192880B (en) | 1990-05-09 |
DE3709699C2 (de) | 1996-09-05 |
SE8701118L (sv) | 1988-01-26 |
CH671578A5 (ko) | 1989-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP9600448A2 (hu) | Naftilvegyületek, e vegyületeket tartalmazó gyógyszerkészítmények, eljárás előállításukra, intermedierjeik és alkalmazásuk | |
KR900014367A (ko) | 피롤리딘 유도체 | |
KR900701282A (ko) | 심장 또는 뇌의 허혈성 질환의 치료, 예방제 | |
DE69713526D1 (de) | Lösliche prodrugs von paclitaxel | |
KR920008026A (ko) | 이소퀴놀리논 유도체 또는 이의 무독성 산부가염 또는 이의 수화물, 이의 제조방법 및 이를 포함하는 약제 조성물 | |
KR890002060A (ko) | 옥사졸리디논 화합물 | |
KR890000470A (ko) | 2,2-디메틸크로만-3-올 유도체, 그의 제조방법 및 그를 함유하는 약학 조성물 | |
KR860006464A (ko) | 6-티오크산틴 유도체 | |
KR910007867A (ko) | 페네타놀아민 화합물 | |
KR830002510A (ko) | 생물학적 활성화합물과 하이드록시알킬 전분으로 구성되는 조성물 | |
KR890006625A (ko) | 2,2-디메틸크로멘 유도체, 그의 제조방법 및 그것을 함유하는 약학 조성물 | |
KR910009259A (ko) | 천식 또는 특정 피부 질환의 치료를 위한 피리미돈 유도체 및 동족체 | |
KR920004387A (ko) | 진통제 및 피부질환 치료용 국소용 소염제로서의 4-치환된 디하이드로피리도[4,3-d]피리미딘 | |
KR910016934A (ko) | 트립토판 동족체 공급에 의한 레베카마이신 동족체 | |
KR880001630A (ko) | 5-플루오로우라실 유도체 및 그의 용도 | |
KR890012942A (ko) | 5-치환된 오르니틴 유도체 | |
KR880004810A (ko) | 소화성 궤양 치료제 | |
KR850006429A (ko) | 새로운 시아노이미다졸 누클레오시드 유도체 및 그 제조방법 | |
KR890007741A (ko) | 진통제 | |
KR880013938A (ko) | 활성 화합물들 | |
KR880009656A (ko) | 국소 치근막 질환의 치료 또는 예방법 | |
KR910011258A (ko) | 녹내장의 치료방법 | |
KR890017363A (ko) | 스트로빌루린 유도체, 이들의 제법 및 용도 | |
KR900701273A (ko) | 진토성 에르골린 유도체 | |
KR880009943A (ko) | 피리다지논 유도체 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 19870701 |
|
PG1501 | Laying open of application | ||
A201 | Request for examination | ||
PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 19920516 Comment text: Request for Examination of Application Patent event code: PA02011R01I Patent event date: 19870701 Comment text: Patent Application |
|
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 19950629 Patent event code: PE09021S01D |
|
G160 | Decision to publish patent application | ||
PG1605 | Publication of application before grant of patent |
Comment text: Decision on Publication of Application Patent event code: PG16051S01I Patent event date: 19950905 |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 19951215 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 19960228 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 19960228 End annual number: 3 Start annual number: 1 |
|
PR1001 | Payment of annual fee |
Payment date: 19980923 Start annual number: 4 End annual number: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 19990916 Start annual number: 5 End annual number: 5 |
|
PR1001 | Payment of annual fee |
Payment date: 20000928 Start annual number: 6 End annual number: 6 |
|
PR1001 | Payment of annual fee |
Payment date: 20010928 Start annual number: 7 End annual number: 7 |
|
PR1001 | Payment of annual fee |
Payment date: 20020918 Start annual number: 8 End annual number: 8 |
|
PR1001 | Payment of annual fee |
Payment date: 20030924 Start annual number: 9 End annual number: 9 |
|
PR1001 | Payment of annual fee |
Payment date: 20040924 Start annual number: 10 End annual number: 10 |
|
FPAY | Annual fee payment |
Payment date: 20050926 Year of fee payment: 11 |
|
PR1001 | Payment of annual fee |
Payment date: 20050926 Start annual number: 11 End annual number: 11 |
|
LAPS | Lapse due to unpaid annual fee | ||
PC1903 | Unpaid annual fee |